pramipexole has been researched along with Neuralgia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Escalona, PR; Haynes, MK; Milligan, ED; Noor, S; Pasmay, A; Sanchez, JE; Sanchez, JJ; Sklar, LA; Sun, MS; Vanderwall, AG; Zimmerly, J | 1 |
| Buonvicino, D; Camaioni, E; Chiarugi, A; Coppi, E; Coppini, R; Dib-Hajj, SD; Estacion, M; Muzzi, M; Pugliese, AM; Ranieri, G; Tanaka, B; Urru, M; Waxman, SG | 1 |
| Brewer, KL; Clemens, S; Dinkins, ML; Lim, SA; Patton, R; Rodgers, HM; Yow, J | 1 |
| de Biase, S; Gigli, GL; Lorenzut, S; Merlino, G; Valente, M | 1 |
1 review(s) available for pramipexole and Neuralgia
| Article | Year |
|---|---|
ADMET considerations for restless leg syndrome drug treatments.
Topics: Amines; Anticonvulsants; Benzothiazoles; Carbamates; Cyclohexanecarboxylic Acids; Dopamine Agents; Dopamine Agonists; Ergolines; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Levodopa; Neuralgia; Pramipexole; Pregabalin; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2012 |
3 other study(ies) available for pramipexole and Neuralgia
| Article | Year |
|---|---|
The FDA-approved compound, pramipexole and the clinical-stage investigational drug, dexpramipexole, reverse chronic allodynia from sciatic nerve damage in mice, and alter IL-1β and IL-10 expression from immune cell culture.
Topics: Animals; Cell Culture Techniques; Cytokines; Drugs, Investigational; Humans; Hyperalgesia; Interleukin-10; Mice; Neuralgia; Peripheral Nerve Injuries; Pramipexole; Rats; Sciatic Nerve; Sciatic Neuropathy; Spinal Cord | 2023 |
Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models.
Topics: Analgesia; Animals; Ganglia, Spinal; Mice; NAV1.7 Voltage-Gated Sodium Channel; NAV1.8 Voltage-Gated Sodium Channel; Neuralgia; Nociception; Pramipexole; Rats; Sodium Channel Blockers; Sodium Channels | 2020 |
Dopamine D
Topics: Analgesia; Analgesics, Opioid; Animals; Chronic Pain; Dopamine Agonists; Dopamine Antagonists; Drug Combinations; Drug Tolerance; Female; Male; Mice; Mice, Inbred C57BL; Morphine; Neuralgia; Pramipexole; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Receptors, Dopamine D3; Substance Withdrawal Syndrome | 2020 |